Skip to content
Checked.be
Complete company report
Generated 10-08-2026
Active BE 1024.211.122Private limited company

BioWorks

Ilse Velden 18 ·2260 Westerlo, Belgium· 1 yrs active
Sector: Wholesale trade (46852)
Conclusion Checked

The computed 12-month bankruptcy probability of BioWorks is 1.0% (low). The 2025 annual accounts show equity of €7.67M and a net result of €-2.33M. Its solvency ranks better than 45% of 335 sector peers (fiscal year 2025). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 1 annual account.
Key figures
Equity €7.67M
Net result €-2.33M
Staff (FTE) 4.6
Better than sector 45%
Snowflake analysis 4 of 5 axes measured · computed by Checked
Health15Profitability0Solvency36Growth-Stability67
30 / 100

Fragile profile, watch profitability in particular.

Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.

Health 15
Profitability 0
Solvency 36
Growth -
Stability 67
Bankruptcy probability (12 mo) Checked model v1 · free
1.0% Low
0%0,5%1,5%4%10%≥25%
Young company +Higher-failure-rate sector +Annual accounts: healthy financial profile −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
Young company
Founded in 2025, under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags 0 events
No administrative flags
Health barometer FY 2025 · computed
15 / 100 Critical
050100
Computed from 4 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview1 NBB filings
Annual accounts filed on 17-07-2026 with the NBB · fiscal year 2025 · verkort
Sector comparison
Fiscal year 2025 · NACE 46, Wholesale trade · compared within the same schema type (abbreviated schema)
Metric This company Sector median Position in the sector
Solvency 29.9% 35.1%
better than 45% of 335 sector peers
Net result €-2.33M €42k
better than 5% of 335 sector peers
Equity €7.67M €278k
better than 95% of 335 sector peers
Gross operating margin €-2.02M €240k
better than 5% of 334 sector peers
Staff costs €211k €172k
higher than 57% of 212 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Fiscal year2025
Revenue-
EBITDA€-2.24M
Net profit€-2.33M
Cash flow€-2.24M
Staff costs€211k
Income taxes-
Dividends-
Total assets€25.66M
Equity€7.67M
Debt€17.99M
of which ≤ 1y€17.99M
of which > 1y-
Working capital€-8.37M
Employees (FTE)4.6
Ratios (computed)
2025
Current ratio0.53
Quick ratio0.53
Working capital ratio-32.6%
Solvency29.9%
Debt / equity2.35
Long-term debt ratio-
Interest coverage-1026.09
Gross margin-
Net margin-
ROA-9.1%
ROE-30.4%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€25.66M
Fixed assets 21/28€16.04M
Intangible fixed assets 21€16.04M
Current assets 29/58€9.62M
Amounts receivable within one year 40/41€9.37M
Cash & bank 54/58€256k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€25.66M
Equity 10/15€7.67M
Contributions / capital 10/11€10.00M
Accumulated profits (losses) 14€-2.33M
Amounts payable 17/49€17.99M
Amounts payable within one year 42/48€17.99M
Trade debts payable within one year 44€17.91M
Income statement
Gross operating margin 9900€-2.02M
Operating result 9901€-2.33M
Financial income 75€991
Financial charges 65€2k
Result before taxes 9903€-2.33M
Net result for the period 9904€-2.33M
Result to be appropriated 9905€-2.33M
Ratios computed by Checked.
Statutory auditor 1 auditor
Statutory auditor IRE/IBR number Tenure
Ernst et Young Reviseurs d'EntreprisesCurrent
Statutory auditor · represented by Carlo-Sebastien D'Addario
 - 28-01-2026 → present
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
NACE primary Wholesale trade(46852)
Legal form Private limited company(610)
Incorporation11-06-2025
StatusActive
Postal code2260
Connections & network 1 connected companies
Group structure
Ernst et Young Reviseurs d'Entreprises
Parent · 926 subsidiaries · 5 locations
Control→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Establishment units 1 location
BioWorks
Ilse Velden 18, 2260 WesterloGroothandel in levende dieren, muv levend vee
since 20252.375.998.172
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
13039C0173/00M000 Flanders 5.7 ha 1 · 1.3 ha 8.1 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 3 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
17-07-2026
NBB filing Annual accounts filed
fiscal year 2025 · verkort
28-01-2026
State Gazette act Director changes
v3.2
2025
13-06-2025
State Gazette act Incorporation
oprichting
Belgisch Staatsblad, acts 2 acts
All acts · 2 updated 6 months ago
2026
28-01-2026 Carlo-Sebastien D'Addario appointed as statutory auditor Director changes
  • Carlo-Sebastien D'Addario, Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Carlo-Sebastien D\u0027Addario",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0446334711",
        "name": "EY Bedrijfsrevisoren BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De Bijzondere Algemene Vergadering beslist om als commissaris te benoemen van de vennootschap EY Bedrijfsrevisoren BV, Kouterveldstraat 7B 001 Diegem, RPR (Brussel) 0446.334.711, vertegenwoordigd door Carlo-Sebastien D\u0027Addario en dit voor een termijn van drie jaar over de boekjaren 2025, 2026 en 202"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "1024.211.122",
    "name_full": "BIOWORKS",
    "legal_form": "BV"
  }
}
2025
13-06-2025 Incorporation of a new BV Incorporation
Summary: oprichting
Technical details 
{
  "kind": "oprichting",
  "seat": "2260 Westerlo, Ilse Velden 18",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": {
        "kbo": "0893.948.337",
        "name": "BIOBEST GROUP"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "Ordinary",
      "partner_role": null,
      "holder_org_kbo": "0893.948.337",
      "holder_org_name": "BIOBEST GROUP",
      "contribution_type": "cash",
      "amount_paid_in_eur": 10000000,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 10000,
      "amount_subscribed_eur": 10000000,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 10000000,
  "subject_company": {
    "kbo": "1024.211.122",
    "name_full": "BioWorks",
    "legal_form": "BV"
  },
  "initial_directors": [],
  "incorporation_date": "2025-06-11",
  "post_incorporation_mandates": []
}
Credit advice verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Company registry (CBE) Crossroads Bank
Activities
Groothandel in kunstmeststoffen en andere agrochemische producten46852Speur- en ontwikkelingswerk op biotechnologisch gebied72101
Primary activity highlighted.
Names & trade names
Legal nameNL BioWorks
Registered office
Ilse Velden 18
2260 Westerlo, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same NACE
Syngenta Crop Protection BE 0467.556.628 · Brussel
AGRI NARMONT BE 0804.343.004 · Fernelmont
AGRI-PROFIT BE 0450.269.050 · Lebbeke
PHYTOSYSTEM BE 0774.745.631 · Kortrijk
OREMIN BE 1002.178.066 · Verlaine
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative